Loading

Journal of Neurological Disorders and Stroke

Analysis of Cerebral Perfusion and Vascular Reserve after Combined Revascularization for Moyamoya Disease

Research Article | Open Access

  • 1. Department of Cerebrovascular Surgery, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka-city, 350-1241 Japan
+ Show More - Show Less
Corresponding Authors
Hidetoshi Ooigawa, Departments of Cerebrovascular Surgery, International Medical Center, Saitama Medical University, 1397-1 Yamane, Hidaka-city, Saitama, 350-1241 Japan, Tel: +81-42-984-4111; Fax: +81-42-984-4741
ABSTRACT

Background and purpose: Moyamoya disease is a progressive occlusive disease of the cerebral arteries. Various vascular reconstruction surgeries have been reported, but the most appropriate procedure remains unclear. We have preferred to perform a combined direct and indirect bypass to the Rolandic region to prevent ischemic stroke. The purpose of this study was to evaluate the surgical results of our method using cerebral blood flow (CBF) from single photon emission computed tomography (SPECT).

Methods: This study examined 29 hemispheres in 21 patients (6 males, 15 females; mean age, 33.25 ± 19.26 years; range, 9-67 years). All patients underwent combined vascular reconstruction using a superficial temporal artery (STA) -middle cerebral artery (MCA) anastomosis and encephaloduromyosynangiosis. Regional CBF (rCBF) and cerebrovascular reserve (CVR) were measured using N-isopropyl-p-[123I]- iodoamphetamine (123I-IMP) SPECT before and after the procedure.

Results: Postoperatively, 28 direct bypasses were patent, but one became occluded within 3 months after surgery. Preoperative symptoms completely resolved in all except one case. Three months postoperatively, improvement of rCBF at rest was not evident in the ipsilateral frontal lobe after surgery, but CVR was widely and significantly improved in the frontal lobe involving the motor cortex (preoperative CVR, -1.1 ± 16.1%; postoperative CVR, 14.3 ± 19.7%, p<0.001) and premotor area (preoperative CVR, -2.14 ± 15.9%; postoperative CVR, 10.2 ± 15.9%, p<0.001).

Conclusions: Our combined direct and indirect bypass effectively reduced ischemic symptoms of moyamoya disease and increased CVR. The possibility that transient ischemic attack was more strongly affected by CVR than by CBF was suggested.

CITATION

Ooigawa H, Takeda R, Ikeda T, Nakajima H, Yoshikawa S, et al. (2014) Analysis of Cerebral Perfusion and Vascular Reserve after Combined Revascularization for Moyamoya Disease. J Neurol Disord Stroke 2(2): 1047.

KEYWORDS

•    Moyamoya disease
•    Combined revascularization
•    Single photon emission computed tomography
•    Cerebral blood flow

ABBREVIATIONS

SPECT: Single Photon Emission Computed Tomography; Cbf: Cerebral Blood Flow; Rcbf: Regional Cerebral Blood Flow; Cvr: Cerebral Vascular Reserve; 123i-Imp: N-Isopropyl-P-[123i]- Iodoamphetamine; Sta: Superficial Temporal Artery ; Mca: Superficial Temporal Artery; Mri: Magnetic Resonance Imaging; 3d-Cta: Three Dimension-Computed Tomographic Angiography; Icga: Indocyanine Green Fluorescence Videoangiography; Acz: Acetazolamide; Dtarg: Dual Table Autoradiographic; Qspect: Quantitative Spect; 3d-Srt: Three-Dimensional Stereotactic Roi Template; Roi: Region Of Interest; Ich Intracerebral Hemorrhage; Ems: Encephalomyosynangiosis; Eds: Encephalodurosynangiosis; Eas: Encephaloarteriosynangiosis; Edams: Encephaloduroarteriomyosynangiosis; Tia: Transient Ischemic Attack; Aca: Anterior Cerebral Artery; Pca: Posterior Cerebral Artery

INTRODUCTION

Moyamoya disease is a cerebrovascular disease characterized by progressive stenosis of the terminal portion of the internal carotid artery, proximal portion of the anterior cerebral artery and middle cerebral artery (MCA) [1]. Two patterns of onset are known: ischemic attacks; and hemorrhagic attacks [2].No effective medical treatment for moyamoya disease has yet been identified. However, surgical revascularization has been validated, particularly for patients with ischemic symptoms. Many efficient surgical procedures have been reported, including direct and indirect revascularization [3-12]. We have been performing surgery applying a combination of both direct and indirect revascularizations. This procedure has two characteristics. One is the place of the direct revascularization, which is constructed mainly in the precentral sulcus, with the aim of preventing postoperative paralysis as the first priority. The other is the use of thin temporalis muscle for indirect anastomoses. Indirect bypass involves both dura mater turned under the skull and temporalis muscle torn into thin sheets to prevent brain compression. We report herein the clinical outcomes of this technique using cerebral perfusion and vascular reserve capacity as measured by N-isopropyl-p-[123I]-iodoamphetamine (123I-IMP) single photon emission computed tomography (SPECT).

MATERIALS AND METHODS

Methods

The medical charts of consecutive patients who underwent the combined direct and indirect bypass surgery after being diagnosed with moyamoya disease at our institution between January 2009 and August 2013 were retrospectively reviewed. Clinical diagnosis of moyamoya disease was accomplished using the criteria proposed by the Research Committee on Spontaneous Occlusion of the Circle of Willis (moyamoya disease) in Japan [13]. Both definite and probable cases were included. Patients with Suzuki stage VI moyamoya [1] were excluded from this study. Cerebral angiography, magnetic resonance imaging (MRI) and 123I-IMP-SPECT were performed preoperatively for all patients. Surgical reconstruction, which involved direct and indirect bypass, was performed in the same manner for all patients. Patency of the direct bypass was examined on three-dimensional computed tomographic angiography (3D-CTA) on the day after surgery and on MRI at both 1 week and 3 months postoperatively. In addition, 123I-IMP-SPECT was performed 3 months after surgery for postoperative evaluation of cerebral perfusion. Clinical outcomes were evaluated at 3 months postoperatively and then every year thereafter, and classified as: 1) no further attack, no ischemic attacks observed postoperatively; 2) improvement, symptoms still observed but at decreased frequency or severity; 3) no change, no new symptoms in patients who had no symptoms previously; or 4) worsened, appearance of new symptoms or increased frequency of ischemic attack.

Surgical reconstruction procedure

Our surgical procedure consisted of direct and indirect bypass, i. e. , anastomosis of superficial temporal artery (STA) to MCA with encephaloduromyosynangiosis. Our standardized direct bypass procedures were as follows. The parietal branch of the STA was dissected out about 7-8 cm from the scalp after making a linear skin incision just over the course of the vessel. A curvilinear frontotemporal skin flap was made, including the temporal fascia. Temporalis muscle was cut and dissected from the skull in the same fashion as the skin flap. The frontal branch of the STA was preserved to maintain blood supply to both the scalp and the indirect bypass in the future. Craniotomy was performed to expose the precentral gyrus in the microscopic surgical field. Although the size of craniotomy varied depending on the anatomical variation of the parietal branch, a 6´6-cm craniotomy was usually performed. Dural opening was made to allow for triangular dural flap. The cortical surface in the central or precentral sulcus was inspected and an adequate M4 artery in the area was chosen as a donor. After preparation of the anastomosis on the brain surface, the distal end of the parietal branch was cut and cleaned. An STA-MCA anastomosis was then completed in side-to-end fashion. The anastomosis was tested for patency with both intraoperative indocyanine green fluorescence videoangiography (ICGA) and using an ultrasonic blood flow meter. After direct arterial reconstruction, an indirect bypass was constructed. The arachnoid membrane was opened widely over the brain surface. The triangular dural flap described above was turned under from the craniotomy edge and laid directly on the cortical surface. Temporalis muscle was torn into two thin pieces, then the thin muscle sheet was placed on the brain surface in which the direct bypass had already been constructed. Closure was performed in the usual method using the other thin muscle sheet.

SPECT procedure

Quantitative regional cerebral blood flow (rCBF) and cerebrovascular reserve (CVR) in response to acetazolamide (ACZ) challenge were evaluated using a dual-table autoradiographic quantitative SPECT method with 123I-IMP, as previously described in detail [14-16]. All patients were scanned on a gamma camera imaging system (Symba T6 SPECT/CT Imaging System; Siemens, Germany) for 60 min. Before SPECT was performed, an intravenous line was inserted. Each patient received the first intravenous injection of 111 MBq of 123I-IMP while lying in prone at the beginning of the examination. One gram of ACZ was injected 20 min later, and a second injection of 111 MBq of 123IMP was made 30 min after the first 123I-IMP injection.

Assessment of rCBF

Values of rCBF were calculated using a 3-dimensional stereotactic region of interest (ROI) template (3D-SRT; Fuji Film RI Pharma, Japan) [17]. Twelve ROIs, including the motor cortex, were placed in each cerebral hemisphere using 3D-SRT.

The rCBF of the motor cortex and premotor area at rest and under ACZ challenge were compared between pre- and postoperative states. In addition, CVR was calculated according to the following equation:

CVR = (rCBF after ACZ challenge – rCBF at rest) /rCBF at rest’100

Statistical analysis

All values are expressed as mean ±standard deviation. Continuous data between before and after surgery were compared using paired t-tests. The Wilcoxon signed-rank test was used for comparison of CVR data. Values of P < 0.05 were considered statistically significant.

RESULTS

Twenty-nine hemispheres in 21 patients (6 males, 15 females; mean age, 33.25 ± 19.26 years; range, 9-67 years) were included in this study (Table 1). The initial pattern of onset was transient ischemic attack (TIA) in 9 patients, cerebral infarction in 5, syncope in 1, epilepsy in 1, and intracerebral hemorrhage (ICH) in 1; 4 patients remained asymptomatic prior to diagnosis. Preoperative Suzuki angiographic stage was stage II in 2 hemispheres, stage III in 17, stage IV in 6 and stage V in 4. Surgical reconstruction was performed in all 29 hemispheres. Postoperatively, 28 direct bypasses remained patent throughout follow-up up to 3 months, but the remaining bypass (Case 9) became occluded within 3 months. Significant complications due to reconstruction surgery, such as ischemic or hemorrhagic stroke, were not observed in any patients. Ten of the 11 symptomatic patients with TIA, epilepsy or syncope showed complete resolution of symptoms after surgery, and frequency of TIA was markedly decreased in the remaining 1 patient. Six patients with a history of cerebral infarction or ICH did not experience any kind of postoperative stroke. The 4 patients with asymptomatic moyamoya disease remained asymptomatic after surgery. No ischemic or hemorrhagic stroke has been recognized after surgery in any of the 29 hemispheres during follow-up (mean, 25.4 ± 15.2 months; range, 3-57 months).

In the SPECT study, rCBF at rest in the motor cortex before and after reconstruction surgery was 25.8 ± 4.0 ml/100 g/min and 26.4 ± 4.7 ml/100 g/min, respectively. In the premotor area before and after reconstruction surgery, rCBF was 29.5 ± 4.3 ml/100 g/min and 30.1 ± 5.5 ml/100 g/min (Figure 1). No significant differences in rCBF at rest were seen between pre- and postoperatively. On the other hand, rCBF under ACZ challenge in the motor cortex before and after reconstruction surgery was 25.4 ± 5.8 ml/100 g/min and 30.3 ± 8.1 ml/100 g/min, respectively. In the premotor area before and after reconstruction surgery, rCBF was 28.9 ± 6.7 ml/100 g/min and 32.7 ± 7.6 ml/100 g/min (Figure 2). A significant difference in rCBF under ACZ challenge (p < 0.001 in motor cortex; p = 0.006 in premotor area) was seen between pre- and postoperatively. CVR in the motor cortex before and after reconstruction surgery was -1.1 ± 16.1% and 14.3 ± 19.7%, respectively. CVR in the premotor area before and after reconstruction surgery was -2.14 ± 15.9% and 10.2 ± 15.9%, respectively (Figure 3). A significant increase in CVR was seen after vascular reconstruction (p < 0.001 in both areas).

DISCUSSION

Various vascular reconstruction techniques have been reported for patients with moyamoya disease [3-12]. Those neurological symptoms after STA-MCA bypass with encephalomyoarteriosynangiosis (EMAS). Mizoi et al. also reported surgical results of combined revascularization involving direct STA-MCA bypass and EMS [4]. Twenty-seven of 30 patients experienced resolution of presenting symptoms after the surgery. The authors identified a significant difference in surgical procedure between direct and indirect bypasses, based on differences in the existing vasculature depending on age. Our bypass surgery was conducted with the primary aim of improving rCBF in the motor area, and almost all patients experienced complete resolution of symptoms. Only one patient showed their preoperative symptoms postoperatively, but the frequency of TIA was dramatically diminished in that case. Our results thus appear comparable or superior to those reported previously [5,9,10].

SPECT is a useful modality for evaluating of rCBF and CVR, which can be calculated after intravenous administration of a vasodilator. Many reports of moyamoya patients have described decreased rCBF and CVR that can be improved by vascular reconstruction surgery [10-12]. Touho et al. reported rCBF and CVR in response to ACZ challenge after vascular reconstruction using combined bypass surgery (STA-MCA anastomosis with EMS or other indirect bypass) [9]. They showed improvements to both rCBF and CBV after the surgery. However, the area of improvement was restricted to within the MCA territory. Cerebral perfusion in the territory of both the anterior cerebral artery (ACA) and posterior cerebral artery (PCA) remained poor. The authors described indirect bypass which composed of tissue such as omentum could be a potential treatment of choice for ischemia in the territory of the ACA and PCA. Young et al. described the utility of postoperative CVR measured using ACZ challenge as a predictor of clinical outcomes [12]. Patients with preserved CVR on postoperative SPECT experienced more favorable clinical outcomes compared to those with decreased CVR. In the present study, significant increases in rCBF at rest were not recognized in the MCA territory. However, rCBF after administration of vasodilator and CVR were significantly improved. Decreased reactivity to ACZ is thought to be due to decreases in CVR capacity and vasodilation at rest, which occurs to compensate for proximal stenosis [9]. The present results suggest that our procedure could contribute to rises in rCBF velocity and vasoconstriction at rest for moyamoya patients. TIA in patients with moyamoya disease was thought to be caused not by the rCBF decrease itself, but rather by loss of CVR.

Table 1: Clinical Characteristics of All Cases.

Case No. Age Sex Suzuki's stage Surgical Side Initial Onset Clinical Outcome
1 9 M 4 R TIA Improvement
    M 4 L    
2 27 F 3 L TIA No further attack
    F 3 R    
3 67 F 4 R incidental No change
4 54 F 3 R incidental No change
5 57 F 3 L TIA No further attack
6 13 M 3 R incidental No change
7 59 F 3 R cerebral infarction No further attack
8 31 F 3 R epilepsy No further attack
9 34 F 3 L TIA No further attack
    F 3 R    
10 39 F 3 R TIA No further attack
11 45 F 3 R TIA No further attack
    F 3 L    
12 48 F 2 R TIA No further attack
    F 3 L    
13 39 M 5 R ICH No further attack
14 37 M 2 R cerebral infarction No further attack
15 44 F 5 R cerebral infarction No further attack
    F 5 L    
16 55 F 4 L cerebral infarction No further attack
    F 5 R    
17 20 F 3 R syncope No further attack
    F 3 L    
18 50 F 3 L TIA No further attack
19 53 F 4 R incidental No change
20 38 M 4 R cerebral infarction No further attack
21 10 F 3 L TIA No further attack

 

CONCLUSION

Hemodynamic impairment was recognized in patients with moyamoya disease. Our combined direct and indirect surgical reconstruction contributed to the resolution of presenting symptoms, particularly TIA. Cerebral perfusion study using SPECT showed significant improvements in postoperative CVR in the ipsilateral frontal lobe, including the motor cortex, although rCBF at rest in the same area was unchanged. Long-term follow-up study is needed to evaluate whether this vascular reconstruction procedure can reduce the risk of further stroke.

REFERENCES

1. Suzuki J, Takaku A. Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969; 20: 288-299.

2. Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 2008; 7: 1056-1066.

3. Matsushima T, Inoue T, Suzuki SO, Fujii K, Fukui M, Hasuo K. Surgical treatment of moyamoya disease in pediatric patients--comparison between the results of indirect and direct revascularization procedures. Neurosurgery. 1992; 31: 401-405.

4. Mizoi K, Kayama T, Yoshimoto T, Nagamine Y. Indirect revascularization for moyamoya disease: is there a beneficial effect for adult patients? Surg Neurol. 1996; 45: 541-548.

5. Veeravagu A, Guzman R, Patil CG, Hou LC, Lee M, Steinberg GK. Moyamoya disease in pediatric patients: outcomes of neurosurgical interventions. Neurosurg Focus. 2008; 24: E16.

6. Karasawa J, Kikuchi H, Furuse S, Kawamura J, Sakaki T. Treatment of moyamoya disease with STA-MCA anastomosis. J Neurosurg. 1978; 49: 679-688.

7. Abla AA, Gandhoke G, Clark JC, Oppenlander ME, Velat GJ, Zabramski JM, et al. Surgical outcomes for moyamoya angiopathy at barrow neurological institute with comparison of adult indirect encephaloduroarteriosynangiosis bypass, adult direct superficial temporal artery-to-middle cerebral artery bypass, and pediatric bypass: 154 revascularization surgeries in 140 affected hemispheres. Neurosurgery. 2013; 73: 430-439.

8. Wong WW, Hiersche MA, Zouros A, Martin MC. Indirect cerebral revascularization with a temporoparietal fascial flap in pediatric moyamoya patients: a novel technique and review of current surgical options. J Craniofac Surg. 2013; 24: 2039-2043.

9. Touho H, Karasawa J, Ohnishi H. Preoperative and postoperative evaluation of cerebral perfusion and vasodilatory capacity with 99mTc-HMPAO SPECT and acetazolamide in childhood Moyamoya disease. Stroke. 1996; 27: 282-289.

10. Nochide I, Ohta S, Ueda T, Shiraishi M, Watanabe H, Sakaki S, et al. Evaluation of cerebral perfusion from bypass arteries using selective intraarterial microsphere tracer after vascular reconstructive surgery. AJNR Am J Neuroradiol. 1998; 19: 1669-1676.

11. Marushima A, Tsurushima H, Suzuki K, Nakai Y, Nemoto H, Matsumura A. Time-course analysis of brain perfusion single photon emission computed tomography using a three-dimensional stereotactic region-of-interest template in patients with moyamoya disease. World Neurosurg. 2011; 76: 304-310.

12. So Y, Lee HY, Kim SK, Lee JS, Wang KC, Cho BK, et al. Prediction of the clinical outcome of pediatric moyamoya disease with postoperative basal/acetazolamide stress brain perfusion SPECT after revascularization surgery. Stroke. 2005; 36: 1485-1489.

13. Fukui M. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (’moyamoya’ disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg. 1997; 99(Suppl 2): S238-S240.

14. Yoneda H, Shirao S, Koizumi H, Oka F, Ishihara H, Ichiro K, et al. Reproducibility of cerebral blood flow assessment using a quantitative SPECT reconstruction program and split-dose 123I-iodoamphetamine in institutions with different γ-cameras and collimators. J Cereb Blood Flow Metab. 2012; 32: 1757-1764.

15. Iida H, Nakagawara J, Hayashida K, Fukushima K, Watabe H, Koshino K, et al. Multicenter evaluation of a standardized protocol for rest and acetazolamide cerebral blood flow assessment using a quantitative SPECT reconstruction program and split-dose 123I-iodoamphetamine. J Nucl Med. 2010; 51: 1624-1631.

16. Kim KM, Watabe H, Hayashi T, Hayashida K, Katafuchi T, Enomoto N, et al. Quantitative mapping of basal and vasareactive cerebral blood flow using split-dose 123I-iodoamphetamine and single photon emission computed tomography. Neuroimage. 2006; 33: 1126-1135.

17. Takeuchi R, Yonekura Y, Matsuda H, Konishi J. Usefulness of a three-dimensional stereotaxic ROI template on anatomically standardised 99mTc-ECD SPET. Eur J Nucl Med Mol Imaging. 2002; 29: 331-341.

Ooigawa H, Takeda R, Ikeda T, Nakajima H, Yoshikawa S, et al. (2014) Analysis of Cerebral Perfusion and Vascular Reserve after Combined Revascularization for Moyamoya Disease. J Neurol Disord Stroke 2(2): 1047.

Received : 25 Dec 2013
Accepted : 27 Jan 2014
Published : 29 Jan 2014
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X